Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Leczux** is a Tabros Pharma oral fixed-dose osmotic-laxative powder supplied in sachets for constipation. The product contains macrogol 3350 with the electrolytes sodium chloride, sodium bicarbonate, and potassium chloride. Macrogol retains water in the intestinal lumen, softening and increasing stool volume to promote bowel motility; the electrolyte components help maintain electrolyte balance during treatment. ([nmp.com.pk](https://nmp.com.pk/product/leczux-sachet))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Leczux.